Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
This guide analyzes beta values across leading coins to identify those with the lowest market sensitivity. Explore interpretation and strategy tips.
26,618 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Oil futures have repeatedly crossed the $100 mark, moving above and below with surprising regularity. This article br...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
A caller revealed a concealed debt load of $650,000 on a national investing show. The incident underscores growing fi...
Meet MIB: Vimal Kapur, Chairman and CEO of Honeywell, as we dive into his plan to split the company into three units ...
A billionaire shifted away from cloud giants to AI infrastructure plays. This article explains what drove the move an...
BP plc shares slipped as leadership changes hit the headlines and energy markets swung on oil-price moves. This artic...
A nuclear startup teams with a national lab to speed up reactor design using AI. This piece breaks down what it could...
Beeline Holdings signaled a strategic move to buy the remaining stake in AI tech firm MagicBlocks, aiming to turn it ...
With an average $70,000 salary in the crosshairs, this explainer shows the math and the risks behind replacing work i...
Burlington Stores keeps evolving in a crowded value retail market. After Q1 2026, investors should focus on margins, ...
A new bill could change the way Americans save for a home by offering tax-free growth for down payments. This article...